title: Why are patients with malignant lymphomas excluded from clinical trials? The experience of an oncology institute in Italy.
authors.forename: D
authors.initials: D
authors.lastname: Serraino
authors.forename: V
authors.initials: V
authors.lastname: Zagonel
authors.forename: R
authors.initials: R
authors.lastname: Bordonaro
authors.forename: S
authors.initials: S
authors.lastname: Franceschi
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D002986:Clinical Trials as Topic; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D008875:Middle Aged; D018579:Patient Selection